Delphi Diagnostics Inc. is a Texas-based company focused on advancing clinically valid tests for the prognosis and prediction of breast cancer treatment. Delphi Diagnostics, Inc. holds an exclusive license from The University of Texas MD Anderson Cancer Center in Houston, TX to commercialize the Endocrine Activity Index, a technology that was developed by the laboratory of Dr. W. Fraser Symmans. The Endocrine Activity Index (EAI) test measures endocrine activity in stage II-III, HR+HER2- breast cancer. Delphi’s vision is to make the EAI test available to breast cancer patients and open new pathways for personalized breast cancer treatment.
| Website | https://www.delphi-diagnostics.com |
| Employees | 16 (11 on RocketReach) |
| Founded | 2016 |
| Phone | +1 281-796-9032 |
| Industry | Biotechnology Research |
| Keywords | Cancer Risk Assessment, Diagnostic Testing, Pathology Testing, Cancer Diagnostics, Molecular Diagnostics, Cancer Testing, Oncology Testing, Cancer Biomarkers, Clinical Diagnostics, Predictive Oncology, Medical Diagnostics, Tumor Diagnostics, Precision Oncology, Breast Cancer Treatment, Personalized Cancer Care |
| Competitors | Siemens Healthineers, Roche, Thermo Fisher Scientific, Abbott, BD, Agilent Technologies, Illumina, PerkinElmer, Inc., Bio-Rad Laboratories, Meridian Bioscience Inc. +38 more (view full list) |
Looking for a particular Delphi Diagnostics Inc. employee's phone or email?
Delphi Diagnostics Inc. Questions
Winz Casagrande is the CEO and Chair of Delphi Diagnostics Inc..
11 people are employed at Delphi Diagnostics Inc..
Delphi Diagnostics Inc. is based in Houston, Texas.
Top Delphi Diagnostics Inc. Employees
-
13
-
13
-
14
-
Emily Granger
Director, Marketing at Delphi Diagnostics Inc.
Boston, MA, US32 -
Condie Carmack
Clinical Operations at Delphi Diagnostics Inc.
Houston, TX, US24 -
Karla Mb
Laboratory Manager at Delphi Diagnostics Inc.
Houston, TX, US1 -
13
-
Emilio Aguilar Zahar
Intern at Delphi Diagnostics Inc.
Richmond, TX, US
Related Companies
